Latest International Expansion News

Page 32 of 42
EZZ Life Science Holdings marked a pivotal quarter with the launch of its EZZDAY brand in the US, a significant Southeast Asia distribution agreement, and expanded domestic retail presence, driving a 46% jump in customer receipts.
Victor Sage
Victor Sage
29 July 2025
Anagenics Limited reports improved operating cash flow and strong sales from its Bouf Haircare brand, while exploring international expansion and a key licensing deal.
Victor Sage
Victor Sage
28 July 2025
Bubs Australia has appointed Joe Coote as its new CEO, bringing extensive international FMCG and dairy leadership to spearhead its global growth ambitions in infant nutrition.
Victor Sage
Victor Sage
28 July 2025
International Graphite Limited (ASX – IG6) has had its trading suspension lifted following the announcement of a new agreement to develop a graphite processing facility in Europe.
Maxwell Dee
Maxwell Dee
28 July 2025
PainChek Limited has raised A$7.5 million through a strongly supported placement to accelerate its US market entry following anticipated FDA clearance and expand its innovative AI pain assessment technology internationally.
Ada Torres
Ada Torres
28 July 2025
Compumedics has secured two significant four-year distribution agreements in China worth A$24.4 million, reinforcing its strategic foothold in Asia with committed annual growth of at least 10%.
Ada Torres
Ada Torres
28 July 2025
Wrkr Ltd reports sustained positive operating cash flow and strategic investments positioning it for growth despite an anticipated FY25 EBITDA loss. The company’s landmark deals and platform enhancements signal readiness for upcoming regulatory reforms.
Victor Sage
Victor Sage
24 July 2025
Talius Group has reported a net profit of $0.37 million for Q2 2025, driven by a 6% increase in subscriptions and strategic partnerships that expand its market reach in aged care technology.
Victor Sage
Victor Sage
23 July 2025
Papyrus Australia has fully impaired its investments in its Egyptian joint ventures PPYEg and EBFC, citing lack of returns and governance issues ahead of its 2025 audited results.
Victor Sage
Victor Sage
21 July 2025
EVE Health Group has secured regulatory approval enabling prescription access for its lead products Libbo and Dyspro in Australia, setting the stage for a commercial rollout before the end of 2025.
Ada Torres
Ada Torres
21 July 2025
BPH Global Ltd reports a 17.7% revenue increase to A$177,316 in its second month of seaweed sales from Indonesia, signaling early commercial traction and sustainable growth potential.
Ada Torres
Ada Torres
17 July 2025
RLF AgTech reports a robust 74% increase in customer cash receipts for FY2025, alongside a significant expansion of its Australian distribution network and strong pre-orders from China, signaling a promising start to FY2026.
Ada Torres
Ada Torres
17 July 2025